{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:13:00Z","timestamp":1791238380135,"version":"4.1.0"},"reference-count":12,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>HTLV-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) is a neurodegenerative disease of the central nervous system induced by human T-lymphotropic virus type 1. As a potential therapeutic approach, we previously suggested reducing the proviral load by modulating lysine deacetylase activity using valproic acid (VPA) and exposing virus-positive cells to the host immune response. We conducted a single-center, 2-year, open-label trial, with 19 HAM\/TSP volunteers treated with oral VPA. Proviral load, CD38\/HLA-DR expression, and CD8+ lysis efficiency were not significantly affected by VPA. Mean scores of HAM\/TSP disability did not differ between baseline and final visit. Walking Time Test increased significantly (&gt; 20%) in 3 patients and was in keeping with minor VPA side effects (drowsiness and tremor). Walking Time Test improved rapidly after VPA discontinuation. We conclude that long-term treatment with VPA is safe in HAM\/TSP.<\/jats:p>","DOI":"10.1182\/blood-2011-04-349910","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T03:05:49Z","timestamp":1318561549000},"page":"6306-6309","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":46,"title":["Safety of long-term treatment of HAM\/TSP patients with valproic acid"],"prefix":"10.1182","volume":"118","author":[{"given":"St\u00e9phane","family":"Olindo","sequence":"first","affiliation":[{"name":"Service de Neurologie and JE 2503 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gildas","family":"Belrose","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie-Immunologie and JE 2503, Centre Hospitalier Universitaire de Fort-de-France, Martinique, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gillet","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biology, Gembloux Agricultural University, Gembloux, Belgium;"},{"name":"Interdisciplinary Cluster for Applied Genoproteomics, University of Li\u00e8ge, Li\u00e8ge, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biology, Gembloux Agricultural University, Gembloux, Belgium;"},{"name":"Interdisciplinary Cluster for Applied Genoproteomics, University of Li\u00e8ge, Li\u00e8ge, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Boxus","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biology, Gembloux Agricultural University, Gembloux, Belgium;"},{"name":"Interdisciplinary Cluster for Applied Genoproteomics, University of Li\u00e8ge, Li\u00e8ge, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Verlaeten","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biology, Gembloux Agricultural University, Gembloux, Belgium;"},{"name":"Interdisciplinary Cluster for Applied Genoproteomics, University of Li\u00e8ge, Li\u00e8ge, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becca","family":"Asquith","sequence":"additional","affiliation":[{"name":"Department of Immunology, Wright-Fleming Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Bangham","sequence":"additional","affiliation":[{"name":"Department of Immunology, Wright-Fleming Institute, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u00efssatou","family":"Signat\u00e9","sequence":"additional","affiliation":[{"name":"Service de Neurologie and JE 2503 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Smadja","sequence":"additional","affiliation":[{"name":"Service de Neurologie and JE 2503 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Lezin","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie-Immunologie and JE 2503, Centre Hospitalier Universitaire de Fort-de-France, Martinique, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"C\u00e9saire","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie-Immunologie and JE 2503, Centre Hospitalier Universitaire de Fort-de-France, Martinique, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Willems","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Biology, Gembloux Agricultural University, Gembloux, Belgium;"},{"name":"Interdisciplinary Cluster for Applied Genoproteomics, University of Li\u00e8ge, Li\u00e8ge, Belgium; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111809452468600_B1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2019111809452468600_B2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2007.09.006","article-title":"How does HTLV-I persist despite a strong cell-mediated immune response?","volume":"29","author":"Asquith","year":"2008","journal-title":"Trends Immunol"},{"issue":"6","key":"2019111809452468600_B3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP.","volume":"4","author":"Nagai","year":"1998","journal-title":"J Neurovirol"},{"issue":"11","key":"2019111809452468600_B4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archneur.63.11.1560","article-title":"Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study.","volume":"63","author":"Olindo","year":"2006","journal-title":"Arch Neurol"},{"issue":"29","key":"2019111809452468600_B5","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1073\/pnas.0504248102","article-title":"Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia\/lymphoma regression in vivo.","volume":"102","author":"Achachi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2019111809452468600_B6","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2007-04-085076","article-title":"Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1-associated myelopathy\/tropical spastic paraparesis patients.","volume":"110","author":"Lezin","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2019111809452468600_B7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2141.2008.07348.x","article-title":"Reduction of B cell turnover in chronic lymphocytic leukaemia.","volume":"143","author":"Defoiche","year":"2008","journal-title":"Br J Haematol"},{"issue":"12","key":"2019111809452468600_B8","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2006-03-013235","article-title":"Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection.","volume":"108","author":"Mosley","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2019111809452468600_B9","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1099\/vir.0.80766-0","article-title":"A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load.","volume":"86","author":"Asquith","year":"2005","journal-title":"J Gen Virol"},{"issue":"1","key":"2019111809452468600_B10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-0934(01)00445-1","article-title":"Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.","volume":"102","author":"Dehee","year":"2002","journal-title":"J Virol Methods"},{"issue":"19","key":"2019111809452468600_B11","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2010-02-270751","article-title":"Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.","volume":"116","author":"Afonso","year":"2010","journal-title":"Blood"},{"key":"2019111809452468600_B12","doi-asserted-by":"crossref","first-page":"A48","DOI":"10.1186\/1742-4690-8-S1-A48","article-title":"Targeting HTLV-I latency in adult T-cell leukemia\/lymphoma.","volume":"8","author":"Ramos","year":"2011","journal-title":"Retrovirology"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/24\/6306\/1343456\/zh805011006306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/24\/6306\/1343456\/zh805011006306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T15:38:27Z","timestamp":1574091507000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/24\/6306\/29186\/Safety-of-longterm-treatment-of-HAMTSP-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,8]]},"references-count":12,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2011,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-04-349910","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,8]]}}}